WH

William D. Huse

IX Ixsys: 19 patents #1 of 12Top 9%
ML Medimmune Limited: 11 patents #28 of 738Top 4%
ST Stratagene: 11 patents #3 of 47Top 7%
AE Applied Molecular Evolution: 10 patents #4 of 32Top 15%
CM Cell Matrix: 5 patents #1 of 5Top 20%
MC Medical Research Council: 3 patents #53 of 405Top 15%
SR Scripps Research: 3 patents #296 of 1,293Top 25%
BS Bristol-Myers Squibb: 2 patents #1,811 of 3,969Top 50%
MI Medical Research Institute: 1 patents #3 of 8Top 40%
Overall (All Time): #39,524 of 4,157,543Top 1%
60
Patents All Time

Issued Patents All Time

Showing 25 most recent of 60 patents

Patent #TitleCo-InventorsDate
8338107 Method for producing polymers having a preselected activity Gregory Paul Winter, Lutz Riechmann, Joseph A. Sorge, Richard A. Lerner 2012-12-25
8153133 High potency recombinant antibodies and method for producing them James F. Young, Leslie S. Johnson, Herren Wu, Jeffry D. Watkins 2012-04-10
7858359 Method for tapping the immunological repertoire Gregory Paul Winter, Lutz Riechmann, Joseph A. Sorge, Richard A. Lerner 2010-12-28
7847082 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment James F. Young, Scott Koenig, Leslie S. Johnson, Jeffrey D. Watkins, Herren Wu 2010-12-07
7763247 Humanized collagen antibodies and related methods Jeffry D. Watkins, Ying Tang, Daniel Broek, Peter Brooks 2010-07-27
7763248 Humanized collagen antibodies and related methods Jeffry D. Watkins, Ying Tang, Daniel Broek, Peter Brooks 2010-07-27
7740851 Ultra high affinity neutralizing antibodies James F. Young, Leslie S. Johnson, Herren Wu, Jeffry D. Watkins 2010-06-22
7700735 High potency recombinant antibodies and method for producing them James F. Young, Leslie S. Johnson, Herron Wu, Jeffrey D. Watkins 2010-04-20
7667007 αvβ3-specific antibodies Herren Wu 2010-02-23
7635568 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment James F. Young, Scott Koenig, Leslie S. Johnson, Jeffrey D. Watkins, Herren Wu 2009-12-22
7566770 Humanized collagen antibodies and related methods Jeffry D. Watkins, Ying Tang, Daniel Broek, Peter Brooks 2009-07-28
7553489 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment James F. Young, Scott Koenig, Leslie S. Johnson, Jeffrey D. Watkins, Herren Wu 2009-06-30
7435799 TNF-α binding molecules Jeffry D. Watkins, Alain P. Vasserot, David Matthew Marquis 2008-10-14
7422745 Methods of treating cancer with vαβ3-specific antibodies Scott Glaser 2008-09-09
7422744 Methods of treating cancer with alphavbeta3-specific antibodies Scott Glaser 2008-09-09
7390885 Humanized collagen antibodies and related methods Jeffry D. Watkins, Ying Tang, Daniel Broek, Peter Brooks 2008-06-24
7371382 Methods of inhibiting αvβ3-mediated binding with αvβ3-specific antibodies Herren Wu 2008-05-13
7365167 Humanized collagen antibodies and related methods Jeffry D. Watkins, Ying Tang, Daniel Broek, Peter Brooks 2008-04-29
7323172 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment James F. Young, Scott Koenig, Leslie S. Johnson, Jeffrey D. Watkins, Herren Wu 2008-01-29
7229619 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment James F. Young, Scott Koenig, Leslie S. Johnson, Jeffrey D. Watkins, Herren Wu 2007-06-12
7179900 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment James F. Young, Scott Koenig, Leslie S. Johnson, Jeffrey D. Watkins, Herren Wu 2007-02-20
7175996 Methods of optimizing antibody variable region binding affinity Jeffry D. Watkins, Herren Wu 2007-02-13
7101978 TNF-α binding molecules Jeffry D. Watkins, Alain P. Vasserot, David Matthew Marquis 2006-09-05
6893845 Surface expression libraries of heteromeric receptors 2005-05-17
6855493 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment James F. Young, Scott Koenig, Leslie S. Johnson, Jeffrey D. Watkins 2005-02-15